Biotech Worker’s Illness Raises Worries About the Growing, Largely Unregulated, Industry
4/18/2012 7:06:31 AM
David Bell was a senior at University California at Davis when he began to work at Agraquest, a start-up biotech firm. In the five months and nine days between when he was hired, in August 1998, and June 1999, when he was laid off after he fell sick, he worked primarily on two bio-pesticide projects: Laginex and Serenade.
comments powered by